Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MOLAR”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 235 records · Page 13Linked to original sources
PubMed1982

Rotation of rectangular wire in rectangular molar tubes. Part II. Pretorqued molar tubes.

Buccal tubes from five manufactures producing the new generation of preadjusted (straight wire type) appliances were tested to determine the amount of rotation various-sized rectangular wires produced prior to binding within the tube. This rotation reflected the amount of torquing force dissipated because of the interaction of the wires and tube. In addition, it indicated the degree of compensatory third-order bends needed in the wire to deliver the desired torque force to the tooth. Wire and tube dimensions were measured and compared to manufacturers' stated specifications. The amount of rotation for each manufacturer's tube was compared to the theoretical values based on calculations. Theoretical calculations and published charts of deflection angles based on these calculations give a false impression in that they do not revealed a true expression of the amount of torque dissipated through rotation of the rectangular wire in that tube. There is variation between the manufacturer's stated lumen dimension and the actual lumen size, even beyond the manufacturer's stated tolerances. Rectangular wire will rotate within a rectangular buccal tube to varying degrees, depending upon the size of the wire used and the manufacturer of the appliance. This means that additional torsion or angulation may need to be placed in the wire prior to application intraorally. The amount of this additional torquing of the arch wire will depend upon the manufacturer of the appliance used and will vary from tube to tube of the same manufacturer.

Equipment Design↗
PubMed1988

Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.

The rate of regression of the beta subunit of human chorionic gonadotropin in patients successfully treated by single-agent chemotherapy with methotrexate (MTX) for postmolar nonmetastatic gestational trophoblastic neoplasia (NMGTN) has not previously been described. In 21 patients with NMGTN treated with MTX, the rate of regression was determined. Nineteen patients had a log-exponential disappearance of serum beta-hCG titers within 100 days. There was a 50% probability of a negative titer at 50 days. Two patients had plateauing titers within 63 days after therapy. There was no difference in beta-hCG disappearance whether MTX with citrovorum factor or MTX alone was administered. Also, the regression rate of beta-hCG titer in the treated patients was compared to 63 patients with spontaneous decline of titers postevacuation of trophoblastic disease. In the postevacuation group there was a 50% probability at 49 days of negative serum titers. All 63 patients had negative titers within 105 days after evacuation.

Chorionic Gonadotropin↗